Authors:
Moraitou, M
van Weely, S
Verhoek, M
Aerts, J
Dimitriou, E
Michelakakis, H
Citation: M. Moraitou et al., The facile detection of 1505G -> A in Gaucher patients with different phenotypes, BBA-MOL BAS, 1536(2-3), 2001, pp. 97-102
Authors:
Paschke, E
Milos, I
Kreitner-Erlacher, H
Hoefler, G
Hoeltzenbein, M
Kleijer, W
Levade, T
Michelakakis, H
Radeva, B
Citation: E. Paschke et al., Mutation analyses in 17 patients with deficiency in acid beta-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B, HUM GENET, 109(2), 2001, pp. 159-166
Authors:
Delis, D
Michelakakis, H
Katsarou, E
Bartsocas, CS
Citation: D. Delis et al., Thiamin-responsive maple syrup urine disease: Seizures after 7 years of satisfactory metabolic control, J INH MET D, 24(6), 2001, pp. 683-684
Authors:
Murphy, HC
Dolphin, CT
Janmohamed, A
Holmes, HC
Michelakakis, H
Shephard, EA
Chalmers, RA
Phillips, IR
Iles, RA
Citation: Hc. Murphy et al., A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, thatcauses fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy, PHARMACOGEN, 10(5), 2000, pp. 439-451
Authors:
Labadaridis, J
Mavridou, I
Sarafidou, G
Alexiou, N
Costalos, C
Michelakakis, H
Citation: J. Labadaridis et al., Carnitine supplementation and ketogenesis by small-for-date neonates on medium- and long-chain fatty acid formulae, BIOL NEONAT, 77(1), 2000, pp. 25-28
Authors:
Kaloterakis, A
Filiotou, A
Koskinas, J
Raptis, I
Zouboulis, C
Michelakakis, H
Hadziyannis, S
Citation: A. Kaloterakis et al., Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature, J INTERN M, 246(6), 1999, pp. 587-590